Organisation
Department of Basic and Applied Medical Sciences
Department
Current researchers
1 - 10 of 71 results
- Patrick Wouters (Responsible)
- Rosalie Allewaert (Member)
- Bart Blanckaert (Member)
- Frank Bosmans (Member)
- Wayra Brackx (Member)
- Paul Calle (Member)
- Sandra Calvo Blanco (Member)
- Thierry Christiaens (Member)
- Ellen Cocquyt (Member)
- Marc Coppens (Member)
Projects
1 - 10 of 81
- The role of NaV1.9 and GPR35 in inflammatory painFrom1 Nov 2024 → TodayFunding: BOF - doctoral mandates
- Facility : Patiënt-afgeleide xenograft modellen – UGent;From1 Feb 2024 → TodayFunding: BOF - research organisations
- Towards personalized drug dosing in special patient populationsFrom1 Feb 2024 → TodayFunding: BOF - projects
- Impact of gender-affirming therapy started in early puberty on liver and boneFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Sodium channelopathies as a possible cause of Primary Focal HyperhidrosisFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Universal, cost-effective and hypersensitive open-source technology platform for liquid biopsy based on methylome profiling of circulating DNA.From1 Jan 2024 → TodayFunding: BOF - projects
- IIMMUNO—FER—GUARD: Immunotherapy-based Modality Using Dendritic cells Loaded with FERroptotic cancer Lysates - Guarding against Glioblastoma and MelanomaFrom20 Dec 2023 → TodayFunding: IOF - technology concept exploration
- Maternal insulin resistance: fueling offspring fatty liver via metabolic dysregulation?From1 Oct 2023 → TodayFunding: FWO senior postdoctoral fellowship
- Characterisation of an obese piglet model to study drug dosing in obese childrenFrom1 Oct 2023 → TodayFunding: BOF - projects
- Medically Intractable Tachyarrhymias Mediated by Novel Sodium Ion Channel Mutations and Sympathetic OverexcitationFrom1 Oct 2023 → TodayFunding: BOF - projects
Publications
1 - 10 of 1655
- Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma(2016)
Authors: Tijl Vermassen, M. Van de Walle, Sylvie Rottey
Pages: 12 - 18 - REACT expanded-access program in patients with metastatic renal cell carcinoma : real-world data from a European subanalysis(2015)
Authors: S Bracarda, Sylvie Rottey, A Bahl, C Eichelberg, B Mellado, L Mangel, A Cattaneo, A Panneerselvam, V Grunwald
Pages: 2893 - 2903 - Mobile health technology captures 'in-house' data on the outside : an assessment with pharmacological intervention(2019)Volume: 105
Authors: G Bhatia, Q Huang, T Crumley, C Walters, L Cluckers, I Heirman, L Mixson, Sylvie Rottey, M Cantor, C Benko, et al.
Pages: S73 - S73 - Glycosylation of urinary prostate proteins and its potential diagnostic applications(2017)
Authors: Tijl Vermassen
Pages: 126 - 128 - Phase 1 study of AMG 160, a half-life extended BITE (R) (bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer(2020)Volume: 8
Authors: Tanya Dorff, Matthew Rettig, Jean-Pascal Machiels, Martijn Lolkema, Karen Autio, Richard Greil, Sylvie Rottey, Nabil Adra, Mark Salvati, Shirley Poon, et al.
Pages: A207 - A208 - Cytoreductive nephrectomy and exposure to sunitinib : a post hoc analysis of the immediate surgery or surgery after sunitinib malate in treating patients with metastatic kidney cancer (SURTIME) trial(2022)
Authors: Yasmin AbuU+2010Ghanem, Johannes V. Thienen, Christian Blank, Maureen J. B. Aarts, Michael Jewett, Igle Jan Jong, JeanU+2010Baptiste Lattouf, Harm H. E. Melick, Lori Wood, Peter Mulders, et al.
Pages: 68 - 75 - Nephrotoxicity of anticancer drugs: an underestimated problem?(2011)
Authors: VIBEKE KRUSE, Sylvie Rottey
Pages: 337 - 345 - Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial(2013)
Authors: Jan B Vermorken, Jan Stoelmacher-Williams, Irina Davidenko, Lisa Licitra, Eric Winquist, Cristian Villanueva, Paolo Foa, Sylvie Rottey, Krzysztof Skladowski, Makoto Tahara, et al.
Pages: 697 - 710 - A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors(2020)Volume: 80
Authors: Juanita S. Lopez, Ross Camidge, Marco Iafolla, Sylvie Rottey, Martin Schuler, Matthew Hellmann, Ani Balmanoukian, Luc Dirix, Michael Gordon, Ryan Sullivan, et al.
Number of pages: 1 - Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib : the SURTIME randomized clinical trial(2019)
Authors: Axel Bex, Peter Mulders, Michael Jewett, John Wagstaff, Johannes V van Thienen, Christian U Blank, Roland van Velthoven, Maria del Pilar Laguna, Lori Wood, Harm HE van Melick, et al.
Pages: 164 - 170